Variable use of therapeutic interventions for children with human immunodeficiency virus type I infection in Europe

European Journal of Pediatrics

Volumn 159, Issue 3, 2000, Pages 170-175

  Bernardi, S ^a   Thorne, C ^b   Newell, M L ^b   Giaquinto, C ^c   Tovo, P A ^d   Rossi, P ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF PADOVA   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

Author keywords

Antiretroviral drug therapy; Human immunodeficiency virus; Management; Prophylactic drug therapy

Indexed keywords

ABACAVIR; DIDANOSINE; INDINAVIR; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; NUCLEOSIDE DERIVATIVE; RITONAVIR; SAQUINAVIR; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EUROPE; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PNEUMOCYSTIS PNEUMONIA; PRACTICE GUIDELINE; PRIORITY JOURNAL;

EID: 0034055641     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004310050045     Document Type: Article

References (32)

1. 1. Bertolli J, Simonds RJ, Thomas P, Melville S, Ortiz I, Mascola L, Wilfert C, Rakusan T, Hsu H, Maldonado Y (1998) Implementation of recommendations for the medical care of HIV-exposed infants in the first year of life, USA. In: Abstracts, XII International Conference on AIDS, Geneva, p 23269
2. 2. Carpenter CCJ, Fischl MA, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JSG, Richman DD, Saag MS, Schooley RT, Thompson MA, Vella S, Volberding PA (1997) Antiretroviral therapy for HIV infection in 1997: updated recommendations of the International AIDS Society - USA panel. JAMA 277:1962-1969
3. 3. Centers for Disease Control (1994) 1994 Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR Morb Mortal Wkly Rep 43:1-10
4. 4. Centers for Disease Control (1995) 1995 revised guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with or perinatally exposed to human immunodeficiency virus. MMWR Morb Mortal Wkly Rep 44:(RR4) 1-11
5. 5. Centers for Disease Control and Prevention (1995) USPHS/ IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: a summary. MMWR Morb Mortal Wkly Rep 44:1-34
6. 6. Centers for Disease Control and Prevention (1998) Guidelines for the use of antiretroviral agents in pediatric HIV infection. MMWR Morb Mortal Wkly Rep 47:(RR4) 1-43
7. 7. Centers for Disease Control and Prevention (1998) Report of the NIH Panel to Define Principles of Therapy of HIV Infection and Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents. MMWR Morb Mortal Wkly Rep 47:1-82
8. 8. Cohen Stuart J WT, Rijkers GT, Noest A, Boucher AB, Suur MH, de Boer RJ, Geelen S PM, Scherpbier HJ, Hartwig NG, Hooijkaas H, Roos MT, de Graeff-Meeder B, de Groot R, Dutch Study Group for Children with HIV Infections (1998) Early recovery of CD4 + T lymphocytes in children on highly active antiretroviral therapy. AIDS 12:2155-2159
9. 9. Dollfus C, Faye A, Thuret I, Douard D, Firtion G, Deville A, Chauvin JP, Cohen Codar I, Courpotin C (1998) Evaluation of combination therapy including ritonavir in 113 children with human immunodeficiency virus infection (abstract). AIDS 12 [Suppl 4]:S92
10. 10. Eldred LJ, Wu AW, Chaisson RE, Moore RD (1998) Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease. J Acquir Immune Defic Syndr Hum Retrovirol 18:117-125
11. 11. European Collaborative Study (1998) Social care of children born to HIV-infected mothers in Europe. AIDS Care 10:7-16
12. 12. European Collaborative Study (1999) Is zidovudine therapy in pregnant HIV-infected women associated with gestational age and birthweight? AIDS 13:119-124
13. 13. French Pediatric HIV Infection Study Group, European Collaborative Study (1997) Morbidity and mortality in European children vertically infected by HIV-1. J Acquir Immune Defic Syndr Hum Retrovirol 14:442-450
14. 14. Hainaut M, Peltier A, Dehennin N, Zissis G, Gerard M, Levy J (1998) Triple therapy including ritonavir in children with advanced HIV infection. AIDS 12 [Suppl 4]:S94
15. 15. Italian Register for HIV Infection in Children (1994) Features of children perinatally infected with HIV-1 surviving longer than 5 years. Lancet 343:191-195
16. 16. Italian Register for HIV Infection in Children (1999) Italian guidelines for antiretroviral therapy in children with human immunodeficiency virus-type 1 infection. Acta Paediatr 88:228-232
17. 17. Kirk O, Mocroft A, Katzenstein TL, Lazzarin A, Antunes F, Francioli P, Brettle RP, Parkin JM, Gonzales-Lahoz J, Lundgren JD, EuroSIDA Study Group (1998) Changes in use of antiretroviral therapy in regions of Europe over time. AIDS 12:2031-2039
18. 18. Luzuriaga K, Bryson Y, Krogstad P, Robinson J, Stechenberg B, Lamson M, Cort S, Sullivan JL (1997) Combination treatment with zidovudine, didanosine, and nevirapine in infants with human immunodeficiency virus type I infection. N Engl J Med 336:1343-1349
19. 19. Manfredi R, Monari P, Donzelli C, Furlini G, Re MC, Chiodo F (1998) Protease inhibitors in antiviral therapy of paediatric HIV disease. Acta Paediatr 87:814-816
20. 20. Melvin AJ, Mohan KM, Manns Arcuino LA, Edelstein RE, Frenkel LM (1997) Clinical, virologic and immunologic responses of children with advanced human immunodeficiency virus type 1 disease treated with protease inhibitors. Pediatr Infect Dis J 16:968-974
21. 21. Mocroft A, Vella S, Benfield TL, Chiesi A, Miller V, Gargalianos P, d'Arminio Monforte A, Yust I, Bruun JN, Phillips AN, Lundgren JD for the EuroSIDA Study Group (1998) Changing patterns of mortality across Europe in patients infected with HIV-1. Lancet 352:1735-1730
22. 22. Orlandi P, Cancrini C, Scaccia S, Romiti ML, Livadiotti S, Castelli Gattinara G, Angelini F, Cox S, Rossi P (1998) Analysis of HIV-1 reverse transcriptase gene mutations in infected children treated with zidovudine. J Acquir Immune Defic Syndr Hum Retrovirol 19:230-237
23. 23. Paediatric European Network for Treatment of AIDS (1998) HIV-1 viral load and CD4 cell count in untreated children with vertically acquired asymptomatic or mild disease. AIDS 12: F1-F8
24. 24. Rossi A de, Masiero S, Giaquinto C, Ruga E, Comar M, Giacca M, Chieco-Bianchi L (1996) Dynamics of viral replication in infants with vertically acquired human immunodeficiency virus type 1 infection. J Clin Invest 97:323-330
25. 25. Rossum AMC van, Suur MH, Niesters HGM, Geelen SPM, Scherpbier HJ, Burger DM, Osterhaus ADME, de Groot R (1998) Dutch multi-centre trial on the treatment of HIV infected children with zidovudine, indinavir and lamivudine. AIDS 12 [Suppl 4]:S92
26. 26. Shearer W, Quinn TC, LaRussa P, Lew JF, Mofenson L, Almy S, Rich K, Handelsman E, Diaz C, Pagano M, Smeriglio V, Kalish L, the Women, Infants Transmission Study (1997) Viral load and disease progression in infants infected with human immunodeficiency virus type I. N Engl J Med 336:1337-1342
27. 27. USPHS/IDSA (1996) USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: a summary. Ann Intern Med 124:348-368
28. 28. Vigano A, Clerici M, Bricalli D, Saresella M, Difabio S, Principi N, Vella S (1998) Immune reconstitution and role of thymus during potent antiretroviral therapy in vertically HIV-infected children. In: Abstracts, XII International Conference on AIDS, Geneva, p 114/12247
29. 29. WHO (1998) Lipodystrophy and HIV protease inhibitors. WHO Drug Information 12:235-236
30. 30. WHO-EU Collaborating Centre on AIDS (1998) HIV/AIDS surveillance in Europe, report no. 57. EU-WHO Collaborating Centre on AIDS, St. Maurice
31. 31. Working Group on Antiretroviral Therapy (1993) Antiretroviral therapy and medical management of the human immunodeficiency virus-infected child. Pediatr Infect Dis J 12:513-522
32. 32. Yogev R, Stanley K, Nachman SA, Pelton S, McIntosh K, Wiznia A (1997) Virologie efficacy of ZDV+ 3TC vs d4T+ ritonavir vs ZDV+ 3TC+ ritonavir in stable, antiretroviral-experienced HIV-infected children (pediatric ACTG trial 338). In: Abstracts, 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, September 1997, Toronto, LB-6